Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
27 May 2021 - QEM Limited (ASX:QEM) Managing Director Gavin Loyden discusses the invention and advantages of vanadium redox flow batteries with Professor Maria Skyllas-Kazacos of the University of New South Wales.
12 Aug 2021 - eCargo Holdings Limited (ASX:ECG) Group CEO Lawrence Lun provides an introduction to the company's platform, partners and retail brands, discussing how it grows sales in China through a combination of data and technology.
29 Feb 2024 - Mitch Thomas - CFO - Latin Resources (ASX:LRS) is exploring and developing sustainable minerals in Australia and Latin America to provide the planet with environmentally friendly products.
19 Jun 2024 - Patrick Bell, CEO and Director of Finexia Financial Group (ASX:FNX) speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). Topics discussed include the company's Childcare Income Fund and its lending business.
11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.
21 Jun 2022 - BluGlass Limited (ASX:BLG) President Jim Haden discusses shipping an alpha product to a customer, and the development roadmap for the company.
19 Dec 2023 - James Powell, General Manager - Investor Relations, Corporate Affairs and Sustainability for Rural Funds Management presents on the FY23 results of the Rural Funds Group (ASX:RFF).